Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Neurological Disorders

Last data update: Oct 15, 2021. (Total: 42864 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 17 (of 17 Records)

Query Trace: Epilepsy[original query]>>Evidence Synthesis [Product Type]
Machine learning models for decision support in epilepsy management: A critical review.
Smolyansky Eliot D et al. Epilepsy & behavior : E&B 2021 123108273
Genetic Neonatal-Onset Epilepsies and Developmental/Epileptic Encephalopathies with Movement Disorders: A Systematic Review.
Spagnoli Carlotta et al. International journal of molecular sciences 2021 22(8)
Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model.
Yuliwulandari Rika et al. The pharmacogenomics journal 2021
Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: A systematic review and meta-analysis.
Stefanski Arthur et al. Epilepsia 2020 Nov
Systematic Review of the Genetics of Sudden Unexpected Death in Epilepsy: Potential Overlap With Sudden Cardiac Death and Arrhythmia-Related Genes.
Chahal C Anwar A et al. Journal of the American Heart Association 2020 Jan 9(1) e012264
Customized multigene panels in epilepsy: the best things come in small packages.
Pellacani Simona et al. Neurogenetics 2019 Dec
CLINGEN Actionability Report for Phenylketonuria (PKU) - PAH
ClinGen Actionability Working Group
CLINGEN Actionability Report for Glutaric Acidemia I - GCDH
ClinGen Actionability Working Group
CLINGEN Actionability Report for Basal Cell Nevus Syndrome (BCNS) - PTCH1
ClinGen Actionability Working Group
CLINGEN Actionability Report for Neurofibromatosis type 1 - NF1
ClinGen Actionability Working Group
CLINGEN Actionability Report for Tuberous Sclerosis Complex (TSC)-TSC1, TSC2
ClinGen Actionability Working Group
CLINGEN Actionability Report for Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukocenphalopathy, type 1 - NOTCH3
ClinGen Actionability Working Group
CLINGEN Actionability Report for Gaucher Disease - GBA
ClinGen Actionability Working Group
CLINGEN Actionability Report for Cerebral cavernous malformations 1, 2, and 3 - KRIT1, CCM2, PDCD10
ClinGen Actionability Working Group
Cost-effectiveness of screening for HLA-B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States.
Choi Hyunmi et al. Epilepsia 2019 Jun
Diagnostic yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study.
Sánchez Fernández Iván et al. Neurology 2019 Jan
SCN1A testing for epilepsy: application in clinical practice.
TOP